Debt-to-equity of Edesa Biotech, Inc. from 30 Jun 2015 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Edesa Biotech, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2015 to 30 Sep 2024.
  • Edesa Biotech, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was 55%, a 192% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 55% +36% +192% 30 Sep 2024
Q2 2024 42% +23% +122% 30 Jun 2024
Q1 2024 30% +3% +11% 31 Mar 2024
Q4 2023 24% -2.3% -9% 31 Dec 2023
Q3 2023 19% -7.8% -29% 30 Sep 2023
Q2 2023 19% -5% -21% 30 Jun 2023
Q1 2023 27% +13% +96% 31 Mar 2023
Q4 2022 26% +11% +68% 31 Dec 2022
Q3 2022 27% +12% +79% 30 Sep 2022
Q2 2022 24% +6.5% +38% 30 Jun 2022
Q1 2022 14% -8% -37% 31 Mar 2022
Q4 2021 16% -1.3% -7.7% 31 Dec 2021
Q3 2021 15% -3.8% -20% 30 Sep 2021
Q2 2021 17% +2.7% +19% 30 Jun 2021
Q1 2021 22% 31 Mar 2021
Q4 2020 17% 31 Dec 2020
Q3 2020 19% 30 Sep 2020
Q2 2020 14% 30 Jun 2020
Q3 2015 32% 30 Sep 2015
Q2 2015 35% 30 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.